Literature DB >> 6236289

Depressed T lymphocyte function in brain tumor patients: monocytes as suppressor cells.

G W Wood, R A Morantz.   

Abstract

Depressed cellular immune function has been demonstrated in patients with a variety of lymphoreticular and nonlymphoreticular neoplasms, including patients harboring brain tumors. In the present study, peripheral T lymphocytes from more than fifty percent of patients with central nervous system tumors, both primary and metastatic, exhibited depressed incorporation of 3H-thymidine in response to phytohemagglutinin (PHA) when tests were performed in the absence of autologous serum. Increased numbers of monocytes were present within mononuclear cell suspensions from brain tumor patients, and most of the cell populations containing elevated monocytes also exhibited depressed responses to PHA. A role for monocytes as suppressor cells was suggested by the finding that partial reconstitution of T cell function could frequently be effected by adherent cell depletion. However, total reversal of the defect was rare and there was no relationship between monocytes and T cell dysfunction in some patients. The results suggest that while monocytes may be involved in the immune depression seen in some patients with a brain tumor, the complete explanation is as yet unknown.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6236289     DOI: 10.1007/bf00182953

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  22 in total

1.  Suppression of antigen and mitogen induced human T lymphocyte DNA synthesis by bacterial lipopolysaccharide: mediation by monocyte activation and production of prostaglandins.

Authors:  J J Ellner; P J Spagnuolo
Journal:  J Immunol       Date:  1979-12       Impact factor: 5.422

2.  Depressed in vitro peripheral blood lymphocyte response to mitogens in cancer patients: the role of suppressor cells.

Authors:  M Zembala; B Mytar; T Popiela; G L Asherson
Journal:  Int J Cancer       Date:  1977-05-15       Impact factor: 7.396

3.  In vitro reversal of depressed T-lymphocyte function in the peripheral blood of brain tumor patients.

Authors:  G W Wood; R A Morantz
Journal:  J Natl Cancer Inst       Date:  1982-01       Impact factor: 13.506

4.  Prostaglandin-producing suppressor cells in Hodgkin's disease.

Authors:  J S Goodwin; R P Messner; A D Bankhurst; G T Peake; J H Saiki; R C Williams
Journal:  N Engl J Med       Date:  1977-11-03       Impact factor: 91.245

5.  Relationship between monocytosis and T-lmphocyte function in human cancer.

Authors:  G W Wood; J E Neff; R Stephens
Journal:  J Natl Cancer Inst       Date:  1979-09       Impact factor: 13.506

6.  A reevaluation of B-lymphocyte levels in peripheral blood from cancer patients.

Authors:  G W Wood; J R Neff
Journal:  J Natl Cancer Inst       Date:  1978-09       Impact factor: 13.506

7.  The effect of in vivo hydrocortisone on subpopulations of human lymphocytes.

Authors:  A S Fauci; D C Dale
Journal:  J Clin Invest       Date:  1974-01       Impact factor: 14.808

8.  Immunobiology of primary intracranial tumors. Part 1: studies of the cellular and humoral general immune competence of brain-tumor patients.

Authors:  M S Mahaley; W H Brooks; T L Roszman; D D Bigner; L Dudka; S Richardson
Journal:  J Neurosurg       Date:  1977-04       Impact factor: 5.115

9.  Immunobiology of primary intracranial tumours. II. Analysis of lymphocyte subpopulations in patients with primary brain tumours.

Authors:  W H Brooks; T L Roszman; M S Mahaley; R E Woosley
Journal:  Clin Exp Immunol       Date:  1977-07       Impact factor: 4.330

10.  Depressed cell-mediated immunity in patients with primary intracranial tumors. Characterization of a humoral immunosuppressive factor.

Authors:  W H Brooks; M G Netsky; D E Normansell; D A Horwitz
Journal:  J Exp Med       Date:  1972-12-01       Impact factor: 14.307

View more
  7 in total

Review 1.  Immunotherapy for malignant gliomas: emphasis on strategies of active specific immunotherapy using autologous dendritic cells.

Authors:  Steven De Vleeschouwer; Stefaan W Van Gool; Frank Van Calenbergh
Journal:  Childs Nerv Syst       Date:  2004-09-28       Impact factor: 1.475

2.  Autologous tumor cell vaccination combined with adoptive cellular immunotherapy in patients with grade III/IV astrocytoma.

Authors:  F P Holladay; T Heitz-Turner; W L Bayer; G W Wood
Journal:  J Neurooncol       Date:  1996-02       Impact factor: 4.130

Review 3.  Microenvironmental clues for glioma immunotherapy.

Authors:  Michael Platten; Katharina Ochs; Dieter Lemke; Christiane Opitz; Wolfgang Wick
Journal:  Curr Neurol Neurosci Rep       Date:  2014-04       Impact factor: 5.081

Review 4.  Medulloblasoma: challenges for effective immunotherapy.

Authors:  Adam M Sonabend; Alfred T Ogden; Lisa M Maier; David E Anderson; Peter Canoll; Jeffrey N Bruce; Richard C E Anderson
Journal:  J Neurooncol       Date:  2011-12-16       Impact factor: 4.130

Review 5.  Cellular immunotherapy for pediatric solid tumors.

Authors:  Meenakshi Hegde; Alexander J Moll; Tiara T Byrd; Chrystal U Louis; Nabil Ahmed
Journal:  Cytotherapy       Date:  2014-07-28       Impact factor: 5.414

6.  Immunological studies in patients with central nervous system tumors.

Authors:  L Palma; V Moschese; E Galli; C Barbieri; V R Lombardi; P Rossi
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

Review 7.  Immunotherapy for Medulloblastoma: Current Perspectives.

Authors:  Tanvir F Kabir; Charles A Kunos; John L Villano; Aman Chauhan
Journal:  Immunotargets Ther       Date:  2020-04-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.